114 related articles for article (PubMed ID: 21515791)
1. An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.
Hawkins O; Verma B; Lightfoot S; Jain R; Rawat A; McNair S; Caseltine S; Mojsilovic A; Gupta P; Neethling F; Almanza O; Dooley W; Hildebrand W; Weidanz J
J Immunol; 2011 Jun; 186(11):6607-16. PubMed ID: 21515791
[TBL] [Abstract][Full Text] [Related]
2. Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.
Patterson AM; Kaabinejadian S; McMurtrey CP; Bardet W; Jackson KW; Zuna RE; Husain S; Adams GP; MacDonald G; Dillon RL; Ames H; Buchli R; Hawkins OE; Weidanz JA; Hildebrand WH
Mol Cancer Ther; 2016 Feb; 15(2):313-22. PubMed ID: 26719579
[TBL] [Abstract][Full Text] [Related]
3. Identification of breast cancer peptide epitopes presented by HLA-A*0201.
Hawkins OE; Vangundy RS; Eckerd AM; Bardet W; Buchli R; Weidanz JA; Hildebrand WH
J Proteome Res; 2008 Apr; 7(4):1445-57. PubMed ID: 18345606
[TBL] [Abstract][Full Text] [Related]
4. TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models.
Verma B; Neethling FA; Caseltine S; Fabrizio G; Largo S; Duty JA; Tabaczewski P; Weidanz JA
J Immunol; 2010 Feb; 184(4):2156-65. PubMed ID: 20065111
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y
Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451
[TBL] [Abstract][Full Text] [Related]
8. TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms.
Verma B; Jain R; Caseltine S; Rennels A; Bhattacharya R; Markiewski MM; Rawat A; Neethling F; Bickel U; Weidanz JA
J Immunol; 2011 Mar; 186(5):3265-76. PubMed ID: 21282517
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.
Rose AA; Grosset AA; Dong Z; Russo C; Macdonald PA; Bertos NR; St-Pierre Y; Simantov R; Hallett M; Park M; Gaboury L; Siegel PM
Clin Cancer Res; 2010 Apr; 16(7):2147-56. PubMed ID: 20215530
[TBL] [Abstract][Full Text] [Related]
10. Scanning the cell surface proteome of cancer cells and identification of metastasis-associated proteins using a subtractive immunization strategy.
Rasmussen N; Ditzel HJ
J Proteome Res; 2009 Nov; 8(11):5048-59. PubMed ID: 19764822
[TBL] [Abstract][Full Text] [Related]
11. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
[TBL] [Abstract][Full Text] [Related]
12. Characterization, epitope identification and mechanisms of the anti-septic capacity of monoclonal antibodies against macrophage migration inhibitory factor.
Zhang Y; Zeng X; Chen S; Zhang Z; Li P; Yi W; Huang H; Yao J; Li S; Hu C
Int Immunopharmacol; 2011 Sep; 11(9):1333-40. PubMed ID: 21571101
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines.
Yao K; Shida S; Selvakumaran M; Zimmerman R; Simon E; Schick J; Haas NB; Balke M; Ross H; Johnson SW; O'Dwyer PJ
Clin Cancer Res; 2005 Oct; 11(20):7264-72. PubMed ID: 16243796
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between expression of macrophage migration inhibitory factor and prognosis of breast cancer].
Xu XD; Yao C; Lin Y; Wang LP; Ma LL; Wang SM
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):520-3. PubMed ID: 18649765
[TBL] [Abstract][Full Text] [Related]
15. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
16. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC
Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional comparison of MIF ortholog from Plasmodium yoelii with MIF from its rodent host.
Shao D; Zhong X; Zhou YF; Han Z; Lin Y; Wang Z; Bu L; Zhang L; Su XD; Wang H
Mol Immunol; 2010 Jan; 47(4):726-37. PubMed ID: 20004020
[TBL] [Abstract][Full Text] [Related]
18. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
[TBL] [Abstract][Full Text] [Related]
19. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
20. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
